Ronald Villanueva is an Endocrinology/Metabolic physician. OpenAlex indexes 24 publications with 1,222 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1255 Route 70 Ste 31s
Lakewood, NJ 087015973
Telephone
732-908-2200Provider last certified this registry record 23 Jun 2025.
Industry payments
56 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202530 payments
- Novo Nordisk IncProgram year202541 payments
- Corcept TherapeuticsProgram year202529 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
64.1%Insulin Analog19.5%Toujeo Max Solostar23%Lantus Solostar11%Toujeo Solostar9%Tresiba Flextouch U-1009%Humalog Kwikpen U-1008%Tresiba Flextouch U-2008%Novolog Flexpen7%Humalog5%Fiasp Flextouch4%Humalog Kwikpen U-2003%Basaglar Kwikpen U-1003%Lyumjev Kwikpen U-1002%Lyumjev Kwikpen U-2002%Novolog2%Soliqua 100-332%Insulin Lispro Kwikpen U-1001%Xultophy 100-3.61%Levemir Flexpen1%Part D<11 patientsGLP-1 receptor agonist14.2%Ozempic72%Mounjaro17%Trulicity7%Rybelsus3%Victoza 3-Pak1%Part D<11 patients+ 11 more classes in this area
Hormonal (systemic)
23.8%l-Thyroxine21.4%Levothyroxine Sodium67%Synthroid25%Unithroid6%Levoxyl1%Tirosint1%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.4%Methimazole100%Part D≥47 patients+ 5 more classes in this area
Cardiovascular
8.5%Statin4.3%Rosuvastatin Calcium42%Atorvastatin Calcium34%Simvastatin15%Pravastatin Sodium7%Livalo3%Part D<11 patientsACE inhibitor1.3%Lisinopril53%Ramipril38%Enalapril Maleate9%Part D<11 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”